Q32 Bio Inc.QTTBNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank11
3Y CAGR-18.8%
5Y CAGR-28.2%
Year-over-Year Change
Research and development spending
3Y CAGR
-18.8%/yr
vs -7.0%/yr prior
5Y CAGR
-28.2%/yr
Recent acceleration
Acceleration
-11.8pp
Decelerating
Percentile
P11
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $19.16M | -60.2% |
| 2024 | $48.14M | +51.7% |
| 2023 | $31.73M | -11.4% |
| 2022 | $35.81M | -61.5% |
| 2021 | $93.08M | -7.3% |
| 2020 | $100.39M | +12.3% |
| 2019 | $89.40M | +86.4% |
| 2018 | $47.95M | +124.3% |
| 2017 | $21.38M | +275.4% |
| 2016 | $5.69M | - |